Get the app!
Back to Trades

Kewalramani Reshma

CEO & PresidentDirectorCIK 0001735944

Largest Purchase

$3.9M

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Aug 7

Profile

Filings
7
Buy transactions
2
Sell transactions
1
Companies
1
Active
2025–2026

Kewalramani Reshma, CEO & President, Director, accounts for 7 disclosed filings worth $26.0M, all concentrated in VERTEX PHARMACEUTICALS INC / MA (VRTX), active 2025–2026. The record is a roughly balanced mix of buying and selling, with $3.9M in purchases against $6.3M in sales. The largest single open-market purchase on record is $3.9M in VERTEX PHARMACEUTICALS INC / MA. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

7 loaded
Nov 10VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorSell$6.3M
Feb 26VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorTax withheld$2.4M
Feb 19VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorGrant$3.2M
Feb 18VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorTax withheld$6.4M
Feb 12VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorTax withheld$3.9M
Jan 26VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorGrant$0
Aug 7VRTX
VERTEX PHARMACEUTICALS INC / MA
Kewalramani ReshmaCEO & President, DirectorBuy$3.9M

7 filings